Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Corrective Spinal Surgery for Severe Spinal Curvature in People With Ankylosing Spondylitis

10 de novembro de 2026 atualizado por: Qingwen Tao, China-Japan Friendship Hospital

Study on the Efficacy Evaluation of AS Surgical Intervention and the Correlation Between Imaging Sagittal Plane Parameters and Disease Activity

This study is an exploratory self-controlled trial, aiming to preliminarily evaluate the effectiveness and safety of surgical treatment for ankylosing spondylitis.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

35

Estágio

  • Não aplicável

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age ≥18 years.
  • AS confirmed by a rheumatologist using the 1984 modified New York criteria: bilateral grade 2-4 or unilateral grade 3-4 radiographic sacroiliitis plus at least one clinical criterion (inflammatory low-back pain and stiffness for >3 months improving with exercise but not rest; restricted lumbar motion in sagittal and frontal planes; or age- and sex-adjusted restriction of chest expansion). A spine surgeon will confirm deformity and surgical eligibility; the diagnostic evidence and assessors will be recorded.
  • Severe structural spinal or spinopelvic deformity associated with AS.
  • Clinically significant impairment of posture, physical function, activities of daily living, or quality of life related to the deformity.
  • A clinical indication for spine-only single-level or two-level PSO with instrumented fusion, determined by the treating spinal surgical team.
  • Ability and willingness to complete the planned clinical, radiographic, and laboratory assessments.
  • Ability to provide written informed consent.

Exclusion Criteria:

  • Active infection, severe osteoporosis considered to preclude safe PSO by the treating team, or another systemic autoimmune disease likely to confound assessment. SpA-associated psoriasis, uveitis, and inflammatory bowel disease are permitted and will be documented, including activity and treatment.
  • Pregnant or lactating women.
  • With severe cardiovascular or cerebrovascular diseases, liver or kidney - Data collection may be affected by mental or language factors.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: Pedicle Subtraction Osteotomy

To estimate changes in function and sagittal alignment at 12 months after pedicle subtraction osteotomy.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Bath Ankylosing Spondylitis Functional Index(BASFI) from baseline to 12 months after surgery (ΔBASFI)
Prazo: at baseline, 6 months, and 12 months

on the 0-10 scale. A negative change indicates improved function.

at baseline, 6 months, and 12 months
Change in T1 pelvic angle (TPA) from baseline to 12 months after surgery (ΔTPA)
Prazo: at baseline, 6 months, and 12 months

TPA will be measured on the standing lateral full-spine radiograph as the angle between the line connecting the center of the T1 vertebral body to the bicoxofemoral axis and the line connecting the bicoxofemoral axis to the midpoint of the superior endplate of S1. TPA incorporates both global spinal inclination and pelvic retroversion and provides a global measure of sagittal alignment. A negative change indicates improved function.

at baseline, 6 months, and 12 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
the seventh cervical vertebra (C7)-sagittal vertical axis(SVA)
Prazo: at baseline, 6 months, and 12 months

Measured on a full-length standing lateral radiograph as the horizontal distance from the C7 plumb line to the posterior-superior corner of the S1 endplate. Unit: millimeters (mm)

at baseline, 6 months, and 12 months
spinosacral angle(SSA)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the C7 plumb line and the sacral endplate line. Unit: degrees (°)

at baseline, 6 months, and 12 months
Sagittal Pelvic Angle(SPA)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the sacral endplate line and the line connecting the femoral head axis to the C7 plumb line. Unit: degrees (°)

at baseline, 6 months, and 12 months
pelvic incidence(PI)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the line perpendicular to the sacral endplate at its midpoint and the line from that midpoint to the femoral head axis. Unit: degrees (°)

at baseline, 6 months, and 12 months
pelvic tilt(PT)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the vertical line and the line from the femoral head axis to the sacral endplate midpoint. Unit: degrees (°)

at baseline, 6 months, and 12 months
sacral slope(SS)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the sacral endplate line and the horizontal line. Unit: degrees (°)

at baseline, 6 months, and 12 months
Pelvic Incidence(PI)-lumbar lordosis(LL) mismatch
Prazo: at baseline, 6 months, and 12 months

Calculated as PI minus LL. Unit: degrees (°)

at baseline, 6 months, and 12 months
global kyphosis(GK)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the superior endplate of the upper-most tilted vertebra and the inferior endplate of the lower-most tilted vertebra in the kyphotic segment. Unit: degrees (°)

at baseline, 6 months, and 12 months
thoracic kyphosis(TK)
Prazo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of T4 and the inferior endplate of T12. Unit: degrees (°)

at baseline, 6 months, and 12 months
oracolumbar kyphosis(TLK)
Prazo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of T10 and the inferior endplate of L2. Unit: degrees (°)

at baseline, 6 months, and 12 months
lumbar lordosis(LL)
Prazo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of L1 and the superior endplate of S1. Unit: degrees (°)

at baseline, 6 months, and 12 months
Kyphosis apex vertebra
Prazo: at baseline, 6 months, and 12 months

Identified as the vertebra at the apex of the maximal kyphotic curve on the lateral radiograph. Unit: vertebral level (e.g.T8, T9)

at baseline, 6 months, and 12 months
Local osteotomy angle
Prazo: at baseline, 6 months, and 12 months

Measured as the angle created at the osteotomy site between the superior and inferior endplates of the resected/adjacent vertebrae on intraoperative or postoperative imaging. Unit: degrees (°)

at baseline, 6 months, and 12 months
the second cervical vertebra(C2)-the seventh cervical vertebra(C7) lordosis.
Prazo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the inferior endplate of C2 and the inferior endplate of C7. Unit: degrees (°)

at baseline, 6 months, and 12 months
the second cervical vertebra(C2)-the seventh cervical vertebra(C7) sagittal vertical axis(SVA)
Prazo: at baseline, 6 months, and 12 months

Measured as the horizontal distance from the C2 plumb line (vertical line from the C2 centroid) to the posterior-superior corner of C7. Unit: millimeters (mm)

at baseline, 6 months, and 12 months
the first thoracic vertebra(T1) slope
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the superior endplate of T1 and the horizontal line. Unit: degrees (°)

at baseline, 6 months, and 12 months
the first thoracic vertebra(T1) angle
Prazo: at baseline, 6 months, and 12 months

T1 angle measured between the T1 endplate line and the line from the T1 centroid to the C7 centroid. Unit: degrees (°)

at baseline, 6 months, and 12 months
Neck tilt
Prazo: at baseline, 6 months, and 12 months

Neck tilt measured as the angle between the vertical line and the line from the sternal notch to the T1 centroid

at baseline, 6 months, and 12 months
Coronal Cobb angle
Prazo: at baseline, 6 months, and 12 months

Measured as the Cobb angle between the superior endplate of the upper-end vertebra and the inferior endplate of the lower-end vertebra of the coronal curve. Unit: degrees (°)

at baseline, 6 months, and 12 months
Coronal vertical axis
Prazo: at baseline, 6 months, and 12 months

Measured as the horizontal distance from the C7 plumb line to the sacral midline (center of S1). Unit: millimeters (mm)

at baseline, 6 months, and 12 months
Pelvic tilt in the coronal plane
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the horizontal line and the line connecting the bilateral femoral head centers (or the sacral endplate line) on the AP radiograph. Unit: degrees (°)

at baseline, 6 months, and 12 months
proximal junctional kyphosis(PJK)
Prazo: at baseline, 6 months, and 12 months

Measured as the angle between the inferior endplate of the upper instrumented vertebra (UIV) and the superior endplate of the vertebra two levels above the UIV (UIV+2). Unit: degrees (°)

at baseline, 6 months, and 12 months
proximal junctional failure(PJF)
Prazo: at baseline, 6 months, and 12 months

Defined by the presence of proximal junctional fracture, implant failure, or revision surgery at the proximal junction. Unit: event (yes/no)

at baseline, 6 months, and 12 months
Implant failure
Prazo: at baseline, 6 months, and 12 months

Defined as radiographic evidence of screw/rod breakage, loosening, or pullout. Unit: event (yes/no)

at baseline, 6 months, and 12 months
surgical safety outcomes
Prazo: at baseline, 6 months, and 12 months

Recorded as events (yes/no) or continuous measures during the perioperative and follow-up periods, including but not limited to: intraoperative blood loss (mL), operative time (min), length of hospital stay (d), transfusion rate, surgical site/deep infection rate, neurologic deficit, dural tear, deep vein thrombosis/pulmonary embolism, implant failure, revision surgery rate, readmission rate, and mortality. Units: mL / min / d / event (yes/no) / proportion (%). Lower event incidence, less blood loss, and shorter operative time and hospital stay indicate better safety; the converse indicates worse safety. Serious complications (infection, neurologic deficit, implant failure, revision, death) indicate worse safety.

at baseline, 6 months, and 12 months
Ankylosing Spondylitis Disease Activity Score based on C-reactive protein(ASDAS-CRP)
Prazo: at baseline, 6 months, and 12 months

Composite score calculated from four patient-reported items (back pain, duration of morning stiffness, patient global assessment, peripheral joint pain/swelling) and serum CRP using a weighted formula. Minimum = 0; maximum = no fixed upper limit (typically ~0-6; theoretical minimum 0). Higher scores indicate worse disease activity; lower scores indicate better disease activity. Cut-offs: < 1.3 = inactive disease, < 2.1 = low disease activity, > 2.1 = high disease activity.

at baseline, 6 months, and 12 months
C-reactive protein(CRP)
Prazo: at baseline, 6 months, and 12 months

Measured in peripheral venous blood as serum CRP concentration. Minimum = 0 (cannot be negative); maximum = no fixed upper limit (assay-dependent). Unit: mg/L (or mg/dL). Higher concentrations indicate greater systemic inflammatory burden (worse); lower concentrations indicate less inflammation (better). Normal reference is typically < 5 mg/L (some laboratories < 3 mg/L).

at baseline, 6 months, and 12 months
Erythrocyte Sedimentation Rate(ESR)
Prazo: at baseline, 6 months, and 12 months

Measured in peripheral venous blood by the Westergren method as the distance erythrocytes fall at the end of 1 hour. Minimum = 0; maximum = no fixed upper limit (assay-dependent). Unit: mm/h (millimeters per hour). Higher values indicate greater inflammatory activity (worse); lower values indicate better status. Reference ranges are age/sex-specific (e.g., < 15 mm/h in men, < 20 mm/h in women).

at baseline, 6 months, and 12 months
Bath Ankylosing Spondylitis Disease Activity Index(BASDAI)
Prazo: at baseline, 6 months, and 12 months

Derived from six patient-reported items (fatigue, neck/back/hip pain, peripheral joint pain/swelling, enthesitis, severity of morning stiffness, duration of morning stiffness), each scored on a 0-10 numeric rating/visual analogue scale; total = mean of the six items. Minimum = 0; maximum = 10. Unit: 0-10 score (unitless). Higher scores indicate worse disease activity; lower scores indicate better disease activity. Cut-off: < 4 = low disease activity/well controlled; ≥ 4 = active disease.

at baseline, 6 months, and 12 months
36-Item Short Form Health Survey(SF-36)
Prazo: at baseline, 6 months, and 12 months

Thirty-six patient-reported items yield eight domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) and two summary scores (Physical Component Summary [PCS] and Mental Component Summary [MCS]). All domains and summary scores are linearly transformed to a 0-100 scale; minimum = 0, maximum = 100. Unit: 0-100 score (unitless). Higher scores indicate better health-related quality of life; lower scores indicate worse.

at baseline, 6 months, and 12 months
Visual Analogue Scale for Pain(VAS)
Prazo: at baseline, 6 months, and 12 months

The patient marks current status on a 100-mm (or 0-10) horizontal/vertical line; the distance from the "none" anchor to the mark is measured. Minimum = 0; maximum = 100 mm (or 0-10). Unit: mm (or 0-10 score, unitless). In ankylosing spondylitis studies, pain VAS (e.g., back pain over the past week) and patient global assessment VAS (e.g., overall disease status over the past week) are typically measured separately and should be reported as distinct constructs. Higher scores indicate worse pain/overall status; lower scores indicate better status.

at baseline, 6 months, and 12 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

30 de outubro de 2026

Conclusão Primária (Estimado)

1 de julho de 2028

Conclusão do estudo (Estimado)

1 de julho de 2029

Datas de inscrição no estudo

Enviado pela primeira vez

29 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de novembro de 2026

Primeira postagem (Real)

12 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

12 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2025-KY-458-41

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .